Literature DB >> 2564818

Use of DNA probes in detecting carriers of Duchenne muscular dystrophy: selected case studies.

T W Prior1, P A Blasco, J L Dove, R T Leshner, H D Gruemer.   

Abstract

Detection of Duchenne muscular dystrophy carriers by genetic analysis is illustrated by four case studies. The technique is most useful in obligate families, in excluding carrier status in isolated cases, and in families in which the affected child demonstrates a molecular deletion. A major limitation of this technique is that the accuracy of carrier status in isolated (i.e., no family history) cases is limited by the probability that the affected child may represent a new mutation. To improve the carrier risk estimate generated by the DNA data, particularly in isolated cases, we suggest that measuring creatine kinase activities in the serum and performing the genetic analysis on the nonaffected males may be helpful.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2564818

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  3 in total

1.  Clinical chemistry through Clinical Chemistry: a journal timeline.

Authors:  Robert Rej
Journal:  Clin Chem       Date:  2004-12       Impact factor: 8.327

2.  Determination of Duchenne muscular dystrophy carrier status by single strand conformation polymorphism analysis of deleted regions of the dystrophin locus.

Authors:  R I Richards; K Friend
Journal:  J Med Genet       Date:  1991-12       Impact factor: 6.318

3.  Exercise intolerance and recurrent myoglobinuria as the only expression of Xp21 Becker type muscular dystrophy.

Authors:  C Doriguzzi; L Palmucci; T Mongini; L Chiadò-Piat; G Restagno; M Ferrone
Journal:  J Neurol       Date:  1993-05       Impact factor: 4.849

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.